Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials

Journal of the American Academy of Dermatology

Volumn 36, Issue 6 II SUPPL., 1997, Pages

  Cunliffe, W J ^a   Caputo, R ^a   Dreno, B ^a   Forstrom, L ^a   Heenen, M ^a   Orfanos, C E ^a   Privat, Y ^a   Aguilar, A R ^a   Meynadier, J ^a   Alirezai, M ^a   Jablonska, S ^a   Shalita, A ^a   Weiss, J S ^a   Chalker, D K ^a   Ellis, C N ^a   Greenspan, A ^a   Katz, H I ^a   Kantor, I ^a   Millikan, L E ^a   Swinehart, J M ^a   Swinyer, L ^a   Whitmore, C ^a   Czernielewski, J ^a   Verschoore, M ^a   more..

^a Laboratoires Galderma   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; RETINOIC ACID;

ACNE VULGARIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EUROPE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; UNITED STATES;

EID: 0030967382     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(97)70056-2     Document Type: Article

References (13)

1. BA Bernard Adapalene, a new chemical entity with retinoid activity Skin Pharmacol 6 Supp. L 1993 61 69
2. DJ Elbaum Comparison of the stability of topical isotretinoin and topical tretinoin and their efficacy in acne J Am Acad Dermatol 19 1988 486 491
3. D Asselineau MT Cavey B Shroot Control of epidermal differentiation by a retinoic acid analogue unable to bind cytosolic retinoic acid binding proteins (CRABP) J Invest Dermatol 8 1992 128 134
4. B Shroot JM Bernardon B Charpentier New retinoids exhibiting selectivity for the nuclear retinoic acid receptor RARβ J Invest Dermatol 96 1991 577A
5. U Reichert JM Bernardon B Charpentier Synthetic retinoids: receptor selectivity and biological activity BA Bernard B Shroot Pharmacology and the skin Vol 5 1993 117 127 From molecular biology to therapeutics
6. CPF Redfern Molecular makers of retinoid activity in the skin J Invest Dermatol 102 1994 11 12
7. K Fogh JJ Voorhees A Astrom Expression, purification and binding properties of human cellular retinoic acid-binding protein type I and type II Arch Biochem Biophys 300 1993 751 755
8. M Verschoore A Langner H Wolska Vehicle controlled study of CD 271 lotion in the topical treatment of acne vulgaris J Invest Dermatol 100 1993 221A
9. CEM Griffiths JT Elder BA Bernard Comparison of CD 271 (adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression [Abstract] J Invest Dermatol 101 1993 325 328
10. M Verschoore A Langner H Wolska Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris Br J Dermatol 124 1991 368 371
11. BM Burke WJ Cunliffe The assessment of acne vulgaris—the Leeds technique Br J Dermatol 111 1984 83 92
12. A Shalita JS Weiss DK Chalker A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: A multicenter trial J Am Acad Dermatol 34 1996 482 485
13. SA Mandy EG Thorne A comparison of the efficacy and safety of tretinoin cream 0.025% and 0.05% Advances in Therapy 7 1990 94 99